General Archive

Home » Articles » Page 3
  • Two young females wearing casual clothing and backpacks walk towards the doors of a large modern building.
    Articles

    LifeArc awards £3 million to advance promising early rare disease research from the lab to the patient

    Pump-prime funding to help researchers get innovative approaches off the ground

    Read more

  • Scientists at LifeArc
    Articles

    Celebrating the International Day of Women and Girls in Science

    LifeArc celebrates this year’s UN Day for Women and Girls in STEM.

    Read more

  • Dr David Powell, Chief Scientific Officer at LifeArc
    Articles

    Alzheimer’s drug lecanemab approved by US regulator

    LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the…

    Read more

  • Articles

    2022 wrapped – our highlights from a pivotal year

    We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.

    Read more

  • Motor neurons grown from stem cells using complex developmental biology techniques (differentiated these cells from induced pluripotent stem cells/iPSCs (not embryonic stem cells)). In blue is the centre of each cell (the nucleus), and in red is the main structural component of each cell (the cytoskeleton).
    Articles

    MND Collaborative Partnership cautiously welcomes new Government funding

    We cautiously welcome the Government’s announcement on how their £50m commitment into MND research will be spent.

    Read more

  • Articles

    Repurposed flu medicine could help under 60s recover faster from COVID-19

    Results of an international repurposing study show favipiravir could help with COVID-19.

    Read more

  • Photo of older woman with her carer
    Articles

    LifeArc plays key role in discovery of new Alzheimer’s treatment

    LifeArc played an important part in the discovery of lecanemab, an experimental drug that has shown some benefits for people…

    Read more

  • Kevin Gillen, LifeArc
    Articles

    LifeArc contributes to organic chemistry breakthrough

    The findings reveal that seemingly impossible chemical reactions can be driven through a phenomenon called quantum tunnelling.

    Read more

  • Articles

    AbbVie acquires LifeArc portfolio company DJS Antibodies

    AbbVie will pay DJS shareholders approximately $255 million in cash at closing for the acquisition of DJS

    Read more

  • DNA in LifeArc's Edinburgh laboratory
    Articles

    LifeArc’s new fund to advance gene-based medicines for genetic diseases

    Researchers can now apply for funding to progress exciting gene therapy research.

    Read more

  • LifeArc's Catriona Crombie at the Beacon Drug Repurposing Conference, Oct 22
    Articles

    New toolkit launched to help repurposed medicines reach patients

    The toolkit helps researchers, charities and others navigate the opportunities and challenges of repurposing medicines.

    Read more

  • Finbar Gaffey in lab
    Articles

    LifeArc scientist awarded prestigious industrial fellowship

    LifeArc scientist Finbar Gaffey awarded a coveted industrial fellowship from the Royal Commission for the Exhibition of 1851.

    Read more